期刊文献+

联立方程组新解法考察注射用头孢噻肟钠和维生素B_6注射液与木糖醇注射液配伍的稳定性 被引量:2

Stability investigation of cefotaxime sodium for injection and vitamin B_6 injection compatibility with xylitol injection by means of simultaneous equations new solution
下载PDF
导出
摘要 目的利用联立方程组新解法考察注射用头孢噻肟钠和维生素B6注射液与木糖醇注射液配伍的稳定性。方法用联立方程组新解法计算注射用头孢噻肟钠与维生素B6注射液的含量。分别在25℃和37℃条件下,观察6h内注射用头孢噻肟钠和维生素B6配伍液的外观、pH值及紫外光谱的变化。结果 6h内,注射用头孢噻肟钠和维生素B6与木糖醇注射液配伍液的外观、pH值、紫外光谱及含量无明显变化。结论应用联立方程组新解法测定头孢噻肟钠和维生素B6注射液与木糖醇注射液配伍的稳定性,方法简便、准确,实用性强。 Objective To investigate the stability of cefotaxime sodium for injection and vitamin B6 injection compatibility with xylitol injection by means of simultaneous equations new solution.Methods Calculated the content of cefotaxime sodium for injection and vitamin B6 injection by means of simultaneous equations new solution.Separately under 25℃ and 37℃ conditions,observed the intermixture appearance,pH and ultraviolet spectrograph changes of cefotaxime sodium for injection compatibility with vitamin B6 injection in 6h.Results No marked changes was noted in terms of the appearance,pH value,ultraviolet spectrograph and content in the intermixture of cefotaxime sodium for injection compatibility with vitamin B6 injection in 6h.Conclusion New Vierordt′method to investigate the stability of cefotaxime sodium for injection and vitamin B6 injection compatibility with xylitol injection is simple,accurate and usable.
出处 《临床合理用药杂志》 2013年第4期35-36,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 注射用头孢噻肟钠 维生素B6注射液 木糖醇注射液 配伍 联立方程组新解法 Cefotaxime sodium for injection Vitamin B6 injection Xylitol injection Compatibility New vierordt′method
  • 相关文献

参考文献5

二级参考文献22

  • 1伍玉甜,戴建子,凌冠,任斌,邝翠仪.分光光度法测定盐酸氨溴索片剂含量[J].中国煤炭工业医学杂志,2001,4(5):389-390. 被引量:4
  • 2李冰.头孢噻肟钠与氧氟沙星注射液配伍的稳定性研究[J].药学实践杂志,2004,22(4):224-225. 被引量:3
  • 3王军,王增寿,朱光辉,付翠香.奥硝唑的临床应用及不良反应[J].医药导报,2006,25(7):711-712. 被引量:55
  • 4中国医院制剂规范(第2版),1995年,103页 被引量:1
  • 5Martinez- Beltran J,Canton R, Linares J, et al. Multicentre comparative study on the antibacterial activity of FK- 037, a new parenteral cephalosporin[J].Eur J Clin Microbiol Infect Dis, 1995, 14(3): 244. 被引量:1
  • 6Giamarellos- Bourboulis EJ, Grecka P, Tsitsika A, et al. In- vitro activity of FK 037(Cefoselis), a novel 4(th) generation cephalosporin, compared to cefepime and cefpirome on nosocomial staphylococci and gram- negative isolates[J]. Diagn Microbiol Infect Dis, 2000, 36(3): 185. 被引量:1
  • 7Inoue K, Inoue E, Mitsuhashi S. In vitro antibacterial activities of FK037: a new parenteral cephalosporin[J]. Chemotherapy, 1995, 41(4): 257. 被引量:1
  • 8Climo MW, Markowitz SM, Williams DS, et al.Compari- son of the in- vitro and in- vivo efficacy of FK037, van- comycin, imipenem and nafcillin against staphylococcal specie[J]. J Antimicrob Chemother, 1997, 40(1): 59. 被引量:1
  • 9Kato N, Kato H, Tanaka Y, et al.In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria[J]. Antimicrob Agents Chemother, 1993, 37(5): 957. 被引量:1
  • 10Fu KP, Foleno BD, Lafredo SC,et al.In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad- spectrum cephalosporin[J]. Antimicrob Agents Chemother, 1993, 37(2): 301. 被引量:1

共引文献50

同被引文献30

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部